BAYLOR COLLEGE OF MEDICINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1900-10-30
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.bcm.edu
Cytokine Persistence as a Marker of Inflammation in the at Risk, Low Socioeconomic Status Pediatric Population
Not Applicable
Completed
- Conditions
- Obstructive Sleep Apnea of Child
- Interventions
- Diagnostic Test: Cytokine from blood
- First Posted Date
- 2017-04-28
- Last Posted Date
- 2021-04-26
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 15
- Registration Number
- NCT03134300
- Locations
- 🇺🇸
Texas Childrens Hospital, Houston, Texas, United States
Genetic Influences Between Cognitive Function and BMI
Completed
- Conditions
- Obesity
- First Posted Date
- 2017-04-17
- Last Posted Date
- 2017-04-18
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 869
- Registration Number
- NCT03116334
- Locations
- 🇺🇸
Children's Nutrition Research Center, Houston, Texas, United States
Efficacy of Audio Recorded Guided Imagery vs Deep Breathing Exercises on Functional Gastrointestinal Pain Disorders
Not Applicable
Completed
- Conditions
- Functional Gastrointestinal DisordersAbdominal Pain
- Interventions
- Device: Apple iPod Shuffle
- First Posted Date
- 2017-04-04
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 48
- Registration Number
- NCT03100487
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
Individual Blood Pressure Optimization Based on Cerebral Autoregulation After Implantation of Continuous-flow LVAD
Completed
- Conditions
- Heart-Assist DevicesHeart Failure
- First Posted Date
- 2017-03-28
- Last Posted Date
- 2022-03-25
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 69
- Registration Number
- NCT03093012
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
TACTIC - TAA Specific Cytotoxic T Lymphocytes in Patients With Breast Cancer
Phase 2
Active, not recruiting
- Conditions
- Breast Cancer
- Interventions
- Biological: TAA-specific CTLs
- First Posted Date
- 2017-03-28
- Last Posted Date
- 2024-07-15
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 12
- Registration Number
- NCT03093350
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸Smith Clinic - Harris Health System, Houston, Texas, United States
Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen
Phase 1
Recruiting
- Conditions
- T-non-Hodgkin LymphomaT-cell Acute Lymphoblastic LymphomaT-cell Acute Lymphoblastic Leukemia
- Interventions
- Genetic: Autologous CD5.CAR/28zeta CAR T cellsGenetic: Allogeneic CD5.CAR/28zeta CAR T cells
- First Posted Date
- 2017-03-16
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 42
- Registration Number
- NCT03081910
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸Houston Methodist Hospital, Houston, Texas, United States
An Innovative Virtually Supervised Exercise for Dialysis Patients
Phase 2
Completed
- Conditions
- Hemodialysis ComplicationDiabetesChronic Kidney Failure
- Interventions
- Other: Non-technology foot and ankle exercise programOther: Sensor-based interactive exercise (game-based exercise)
- First Posted Date
- 2017-03-10
- Last Posted Date
- 2019-05-06
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 100
- Registration Number
- NCT03076528
- Locations
- 🇶🇦
Hamad Medical Coorporation, Doha, Qatar
Entolimod, an Adjuvant for Vaccine Augmentation
Early Phase 1
Completed
- Conditions
- Substance Use Disorders
- Interventions
- Biological: Td Vaccine
- First Posted Date
- 2017-02-24
- Last Posted Date
- 2020-09-01
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 40
- Registration Number
- NCT03063736
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Nitric Oxide Supplementation on Neurocognitive Functions in Patients With ASLD
Not Applicable
Completed
- Conditions
- Argininosuccinic AciduriaArgininosuccinate Lyase DeficiencyUrea Cycle DisorderUrea Cycle Disorders, Inborn
- Interventions
- Dietary Supplement: Neo-ASADietary Supplement: Placebo
- First Posted Date
- 2017-02-24
- Last Posted Date
- 2023-02-27
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 16
- Registration Number
- NCT03064048
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta
- First Posted Date
- 2017-02-24
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 11
- Registration Number
- NCT03064074
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇺🇸Oregon Health Science University, Portland, Oregon, United States
© Copyright 2025. All Rights Reserved by MedPath